Evidence for Dietary Management of Histamine Intolerance
International Journal of Molecular Sciences · 20.09.2025 · 26 (18) · 9198
DOI: 10.3390/ijms26189198 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.09.2025. Verfasst von Kirsten Jackson und 4 weiteren Autor:innen. Beteiligte Einrichtung: The IBS Dietitian. Hauptthemen laut MEDLINE: Histamine, Food Intolerance, Food Hypersensitivity. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bioiberica S.A.U..
Abstract (Originalsprache)
Self-reported food intolerances are estimated to affect between 15–20% of the population. Among them, histamine intolerance (HIT) has emerged as a focus of particular interest. It is defined as a disequilibrium between dietary histamine and the capacity of the organism to degrade intestinal histamine, leading to the appearance of intestinal and extra-intestinal symptoms. HIT is thought to be associated with low activity or blockade of diamine oxidase (DAO), the main enzyme for histamine degradation. The diagnosis is hampered by the lack of a validated biomarker and is mainly based on clinical assessment and response to a low histamine diet and reintroduction. The therapeutic approach is centered on dietary management, restricting foods that may increase circulating histamine levels. DAO supplementation has been shown to potentially contribute to histamine degradation in the intestinal lumen, but its activity varies depending on the presence of cofactors and the enzyme’s origin. Limited clinical evidence reflects the difficulty of dietary management and suggests a beneficial role of DAO supplementation on the clinical manifestations associated with HIT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The IBS Dietitian.
- Land and Food Systems, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
- R&D Bioiberica S.A.U., E-08389 Palafolls, Spain.
ORCID-Profile: Wendy Busse
Förderung
- Bioiberica S.A.U.
Zitieren
APA
Jackson, K., Busse, W., Gálvez-Martín, P., Terradillos, A., & Martínez-Puig, D. (2025). Evidence for Dietary Management of Histamine Intolerance. International Journal of Molecular Sciences, 26(18), 9198. https://doi.org/10.3390/ijms26189198
Vancouver
Jackson K, Busse W, Gálvez-Martín P, Terradillos A, Martínez-Puig D. Evidence for Dietary Management of Histamine Intolerance. International Journal of Molecular Sciences. 2025;26(18):9198. doi:10.3390/ijms26189198
BibTeX
@article{Jackson2025,
author = {Jackson, Kirsten and Busse, Wendy and Gálvez-Martín, Patricia and Terradillos, Andrea and Martínez-Puig, Daniel},
title = {Evidence for Dietary Management of Histamine Intolerance},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {18},
pages = {9198},
doi = {10.3390/ijms26189198}
}
EUVIMED